Sec. 405. Reauthorization of the critical path public-private partnership
52 words·~1 min read·
/bill/117/hr/9525/ih/section-405·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Section 566(f) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 360bbb–5(f) ) is amended by striking $1,265,753 for the period beginning on October 1, 2022 and ending on December 16, 2022 and inserting $2,071,232 for the period beginning on October 1, 2022, and ending on February 3, 2023 .
Connections1 off-index
1 reference not yet in our index
- 21 USC 360bbb–5(f)
Citation graph
cites case law
Sec. 405
Reauthorization of the critical path public-private partnership
Cite21 USC 360bbb–5(f)
Cites 1Cited by 0 across 0 sources